Work

Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group

Year: 2012

Type: article

Abstract: to provide recommendations to the NHLBI that would guide informed decisions on research directions and priorities in the field of cardiovascular pharmacogenomics.This meeting was timed

Source: Journal of the American Heart Association

DOI: 10.1161/jaha.111.000554

Authors: Kiran Musunuru, Dan M. Roden, Robin Boineau, Michael R. Bristow, Timothy A. McCaffrey, Christopher Newton‐Cheh, Dina N. Paltoo, Yves Rosenberg, Jay G. Wohlgemuth, Issam Zineh, Ahmed A. K. Hasan

Institutions: Brigham and Women's Hospital, Harvard University, Vanderbilt University Medical Center, National Heart, Lung, and Blood Institute, University of Colorado Anschutz, George Washington University, Massachusetts General Hospital, Quest Diagnostics (United States), United States Food and Drug Administration

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,810

Funders: National Heart, Lung, and Blood Institute, National Human Genome Research Institute

Awards: Pharmacogenomics of Arrhythmia Therapy, Vanderbilt Genome Electronic Records Project

OpenAlex ID: W2129115809

FWCI: 3.989

Cites: 38

Cited by: 22

Related to: 10